With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

MCLEAN, Va.—The Monitoring Association (TMA) is entering a new chapter with the appointment of Whitney A. Doll as CEO and Alan Gillmore as president - two leaders with visions that promise to shape ...

Breast cancer continues to impact millions worldwide, and for many, the diagnosis involves a hormone receptor-positive subtype. 1 These cancers rely on estrogen or progesterone to grow, using hormone ...

This content was provided by Acumen Media for MYmAb Biologics. This advertiser content was paid for and created by Acumen. Neither CBS News nor CBS News Brand Studio, the brand marketing arm of CBS ...

Uterine fibroids are benign tumors that occur in a large proportion of women and interfere with the proper functioning of this organ. One of the factors leading to these proliferative changes appears ...

For connective tissue diseases, the multiplex assay is designed to rapidly detect and identify up to 1275 disease markers per hour. Seamless, microarray-internal calibration and quality control as ...

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...

Humacyte, Inc. announced plans to file an Investigational New Drug (IND) application with the FDA, aiming to conduct first-in-human clinical trials of its small-diameter acellular tissue engineered ...